InsiderTrades.com logo
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

OCTP Insider Trading

Insider Ownership Percentage: 29.83%
Insider Buying (Last 12 Months): £3,104.06
Insider Selling (Last 12 Months): £548,642.88

Oxford Cannabinoid Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Oxford Cannabinoid Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oxford Cannabinoid Technologies Share Price & Price History

Current Price: GBX 0.33
Price Change: ▼ Price Decrease of -0.02 (-5.71%)
As of 04/19/2024 04:34 PM ET

This chart shows the closing price history over time for OCTP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

Oxford Cannabinoid Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/18/2023Indraneil (Neil) MahapatraInsiderSell54,864,288GBX 1£548,642.88
7/17/2023Clarissa Ann Sowemimo- CokeInsiderBuy310,406GBX 1£3,104.06
12/15/2022Clarissa Ann Sowemimo- CokeInsiderBuy1,000,000GBX 1£10,000
12/1/2021Clarissa Ann Sowemimo- CokeInsiderBuy189,594GBX 3£5,687.82
See Full Table
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

SEC Filings (Institutional Ownership Changes) for Oxford Cannabinoid Technologies (LON:OCTP)

14.11% of Oxford Cannabinoid Technologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Oxford Cannabinoid Technologies logo
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
Read More on Oxford Cannabinoid Technologies

Today's Range

Now: GBX 0.33
Low: 0.33
High: 0.35

50 Day Range

MA: GBX 0.43
Low: 0.34
High: 0.55

52 Week Range

Now: GBX 0.33
Low: 0.31
High: 1.60

Volume

3,051,319 shs

Average Volume

4,994,054 shs

Market Capitalization

£3.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Oxford Cannabinoid Technologies?

Oxford Cannabinoid Technologies' top insider investors include:
  1. Clarissa Ann Sowemimo- Coke (Insider)
  2. Indraneil (Neil) Mahapatra (Insider)
Learn More about top insider investors at Oxford Cannabinoid Technologies.
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story